GO:0061651 Atg12 conjugating enzyme activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0061651 (Atg12 conjugating enzyme activity) is a molecular function that transfers Atg12 from one protein to another via thioester bonds, using a cysteine-based E2 mechanism.
• The only known enzyme with this activity is ATG10, which conjugates ATG12 to ATG5 in the ubiquitin-like ATG12 conjugation system.
• The resulting ATG12-ATG5 conjugate acts as an E3-like enzyme that promotes ATG3-mediated lipidation of ATG8 family proteins, a critical step in autophagosome formation [3,5].
• Structural studies of the human ATG12-ATG5 conjugate have revealed how it interacts with ATG3 and enhances its catalytic activity [5,8].
• Dysregulation of ATG12 conjugation is implicated in cancer, neurodegeneration, and infectious diseases, making it a potential therapeutic target [2,4].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) are essential for dissecting the precise roles of ATG10 and ATG12 conjugation in autophagy and disease [1,4].
Description
The Atg12 conjugating enzyme activity (GO:0061651) is a molecular function that catalyzes the transfer of Atg12 from one protein to another through a thioester bond, using a cysteine residue as the active-site nucleophile. This activity is a central step in the ubiquitin-like conjugation systems that drive autophagosome formation, a key process in cellular homeostasis and stress responses. In eukaryotes, the only known enzyme exhibiting this activity is ATG10, which conjugates ATG12 to ATG5, forming a conjugate that subsequently functions as an E3-like enzyme for ATG8 lipidation [1,3]. Researchers study GO:0061651 to understand how autophagy is initiated and regulated at the molecular level. The ATG12-ATG5 conjugate, produced by this activity, is essential for the lipidation of ATG8 family proteins (such as LC3), which anchors them to the autophagosomal membrane and enables cargo recruitment and vesicle expansion [3,5]. Defects in this conjugation pathway have been linked to a range of human diseases, including cancer, neurodegenerative disorders, and viral infections [2,4]. This article provides a comprehensive overview of the Atg12 conjugating enzyme activity, covering its definition, mechanism, key genes, regulatory features, disease associations, and the experimental models used to study it. By integrating authoritative QuickGO data with published literature, we aim to support researchers in designing robust experiments and interpreting their findings in the context of autophagy biology.
Atg12 conjugating enzyme activity At A Glance
| GO ID | GO:0061651 |
|---|---|
| GO term | Atg12 conjugating enzyme activity |
| Ontology | molecular_function |
| Synonym | E2 |
| Major function | Catalyzes the transfer of Atg12 from a thioester-linked intermediate to a target protein, forming a new thioester bond |
| Definition source | QuickGO |
| Known enzyme | ATG10 (in Arabidopsis thaliana and other eukaryotes) |
| Substrate | Atg12 (ubiquitin-like protein) |
| Target | ATG5 (in the ATG12-ATG5 conjugation system) [1,3] |
What Is GO:0061651?
According to the Gene Ontology, Atg12 conjugating enzyme activity (GO:0061651) is defined as the isoenergetic transfer of Atg12 from one protein to another via the reaction X-Atg12 + Y = Y-Atg12 + X, where both the X-Atg12 and Y-Atg12 linkages are thioester bonds between the C-terminal amino acid of Atg12 and a sulfhydryl side group of a cysteine residue. In simpler terms, it is the enzymatic activity that moves Atg12 from a carrier protein to a target protein, forming a covalent bond through a sulfur atom on a cysteine. This activity is synonymous with E2 enzyme function in the context of ubiquitin-like protein conjugation.
Why Is Atg12 conjugating enzyme activity Important in Cell Biology?
The Atg12 conjugating enzyme activity is essential for autophagy, a conserved catabolic process that degrades cytoplasmic components and maintains cellular homeostasis. By catalyzing the formation of the ATG12-ATG5 conjugate, this activity initiates a cascade that leads to the lipidation of ATG8 family proteins, a hallmark of autophagosome formation [3,5]. Dysregulation of this activity has been implicated in various human pathologies, including cancer, neurodegeneration, and infectious diseases, making it a promising target for therapeutic intervention [2,4]. Understanding the molecular details of this activity is therefore critical for both basic autophagy research and translational applications.
• Essential for autophagosome formation and autophagy flux [1,6].
• Required for ATG8 lipidation and membrane recruitment [3,5].
• Implicated in cancer progression and chemoresistance.
• Linked to neurodegenerative diseases such as Alzheimer's and Parkinson's.
• Targeted by viral proteins to modulate host autophagy during infection.
• Plays a role in plant development and stress responses.
• Potential therapeutic target for autophagy-modulating drugs.
• Key to understanding ubiquitin-like conjugation systems.
• Involved in immune responses and pathogen clearance.
• Provides a model for studying E2 enzyme mechanisms [5,8].
Atg12 conjugating enzyme activity: Biological Process, Cellular Component, and Molecular Function
What Happens During Atg12 conjugating enzyme activity?
In simple terms: This activity is like a molecular hand-off: Atg12 is passed from one protein to another, forming a strong chemical bond.
The Atg12 conjugating enzyme activity catalyzes the transfer of Atg12 from a thioester-linked intermediate (e.g., ATG7-Atg12) to a target protein, typically ATG5, forming a new thioester bond. This reaction is analogous to ubiquitin conjugation and is part of the two ubiquitin-like conjugation systems that mediate autophagosome formation. In Arabidopsis thaliana, the ATG12-conjugating enzyme ATG10 is essential for autophagic vesicle formation, and its loss leads to defects in autophagy and plant development. The product, ATG12-ATG5 conjugate, then acts as an E3-like enzyme to promote ATG8 lipidation.
Formation of the ATG12-ATG5 Conjugate
In simple terms: ATG12 is attached to ATG5, creating a pair that helps build the autophagosome.
The conjugation of ATG12 to ATG5 is a key step in autophagy. The ATG12-ATG5 conjugate is formed through the sequential action of ATG7 (E1-like) and ATG10 (E2-like) enzymes [1,6]. Structural studies of the human ATG12-ATG5 conjugate have revealed that it forms a heterodimer that interacts with ATG3 to enhance its catalytic activity [5,8]. This conjugate is required for the lipidation of LC3 and other ATG8 family proteins, which are essential for autophagosome membrane expansion and cargo recruitment [3,5].
Structural Insights into the ATG12-ATG5 Conjugate
In simple terms: The shape of the ATG12-ATG5 pair is important for its function in autophagy.
The crystal structure of the human ATG12-ATG5 conjugate has been solved, revealing a unique fold that is distinct from ubiquitin-like protein conjugates. The structure shows that ATG12 and ATG5 form a tight complex with a conserved interface, and that this complex binds to ATG3 through a region that includes a catalytic cysteine [5,8]. These structural insights explain how the conjugate enhances the E2 activity of ATG3 by rearranging its catalytic site, a process that is critical for efficient LC3 lipidation.
Molecular Mechanism of Atg12 Transfer
In simple terms: The enzyme uses a cysteine residue to temporarily hold Atg12 and then pass it to the target protein.
The catalytic mechanism of Atg12 conjugating enzyme activity involves a conserved cysteine residue in the active site of ATG10. First, ATG12 is activated by ATG7 (E1) and transferred to the active-site cysteine of ATG10, forming a thioester intermediate [1,6]. Then, the Atg12 moiety is transferred to a lysine residue of ATG5, forming an isopeptide bond. This two-step process is isoenergetic and requires no additional ATP, as the energy is conserved in the thioester bond. The reaction is highly specific, with ATG10 recognizing both ATG12 and ATG5.
Regulation of Atg12 Conjugating Enzyme Activity
In simple terms: The activity can be turned on or off by other molecules, such as RNA or viral proteins.
The Atg12 conjugating enzyme activity is regulated at multiple levels. In vitro studies have shown that ribonucleic acid (RNA) can stimulate ATG12-ATG5 conjugation, suggesting a role for RNA in modulating this activity. Additionally, viral proteins such as the SARS-CoV-2 PLpro ubiquitin deconjugase can regulate N-degron recognin-mediated autophagy, potentially affecting ATG12 conjugation. The activity is also controlled by the availability of substrates and the expression levels of ATG10 and ATG5 [1,6].
Key Genes Involved in GO:0061651 Atg12 conjugating enzyme activity
The following genes and proteins are directly involved in or regulate the Atg12 conjugating enzyme activity and its downstream effects.
| Gene | Major Role | Research Relevance |
|---|---|---|
| ATG10 | E2-like enzyme that conjugates ATG12 to ATG5 | Core enzyme for GO:0061651; knockout leads to autophagy defects |
| ATG12 | Ubiquitin-like protein transferred to ATG5 | Substrate for conjugation; essential for autophagosome formation [1,3] |
| ATG5 | Target protein that receives ATG12 | Forms conjugate with ATG12; acts as E3-like enzyme for LC3 lipidation [3,5] |
| ATG7 | E1-like enzyme that activates ATG12 | Required for ATG12 conjugation; upstream of ATG10 |
| ATG3 | E2-like enzyme for LC3 lipidation | Interacts with ATG12-ATG5 conjugate; enhanced by conjugate |
| LC3B | ATG8 family protein lipidated by ATG12-ATG5-ATG3 system | Marker of autophagosomes; downstream of ATG12 conjugation [3,5] |
| GABARAP | ATG8 family protein involved in autophagosome maturation | Lipidated by ATG12-ATG5 system; affects autophagy flux |
| ATG16L1 | Component of the ATG12-ATG5-ATG16L1 complex | Required for LC3 lipidation; interacts with conjugate |
| ATG2 | Peripheral membrane protein involved in autophagosome formation | May be affected by ATG12 conjugation defects |
| ATG9 | Transmembrane protein involved in autophagosome nucleation | Works upstream of ATG12 conjugation |
| VPS34 | PI3K involved in autophagosome nucleation | Upstream regulator of autophagy; not directly conjugating |
| ULK1 | Serine/threonine kinase that initiates autophagy | Regulates upstream of ATG12 conjugation |
| mTOR | Kinase that inhibits autophagy | Negatively regulates ATG12 conjugation via ULK1 |
| AMPK | Kinase that activates autophagy | Positively regulates ATG12 conjugation under energy stress |
| PLpro | SARS-CoV-2 deconjugase | Regulates N-degron recognin-mediated autophagy; may affect ATG12 conjugation |
| ATG12-ATG3 | Protein-protein interaction | Therapeutic target for autophagy modulation |
| ATG16L1 | Complex component | Mutations linked to Crohn's disease; affects ATG12 conjugation |
| IRGM | GTPase involved in autophagy | Regulates autophagy and ATG12 conjugation in response to infection |
How Is Atg12 conjugating enzyme activity Regulated?
The Atg12 conjugating enzyme activity is regulated by multiple mechanisms. Upstream, the ULK1 complex and mTOR signaling control the initiation of autophagy, thereby influencing the availability of ATG12 and ATG10. AMPK can activate autophagy under energy stress, promoting ATG12 conjugation. At the post-translational level, the activity of ATG10 can be modulated by phosphorylation, although specific sites remain to be fully characterized. Additionally, RNA molecules have been shown to stimulate ATG12-ATG5 conjugation in vitro, suggesting a novel layer of regulation. Viral proteins such as SARS-CoV-2 PLpro can interfere with autophagy by deconjugating ubiquitin-like proteins, potentially affecting ATG12 conjugation. Finally, the expression levels of ATG10 and ATG5 are transcriptionally regulated in response to cellular stress [1,6].
Atg12 conjugating enzyme activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| ATG10 | Cancer progression, autophagy defects | ATG10 knockout cancer cell lines (e.g., HeLa, MCF7) [1,4] |
| ATG12 | Neurodegeneration, cancer | ATG12 knockout neurons or cancer cells |
| ATG5 | Crohn's disease, cancer | ATG5 knockout intestinal epithelial cells |
| ATG16L1 | Crohn's disease | ATG16L1 T300A knock-in mice or cells |
| PLpro | COVID-19, autophagy modulation | SARS-CoV-2 PLpro overexpression in lung epithelial cells |
Cancer
Dysregulation of autophagy, including altered ATG12 conjugation, is frequently observed in cancer. ATG10 and ATG12 have been implicated in tumor progression, with some studies suggesting that high expression of these genes correlates with poor prognosis in certain cancers. Targeting the ATG12-ATG3 protein-protein interaction has emerged as a potential therapeutic strategy to modulate autophagy in cancer cells. However, the role of autophagy in cancer is context-dependent, acting as a tumor suppressor in early stages and a survival mechanism in established tumors.
Neurodegenerative Diseases
Impaired autophagy contributes to the accumulation of toxic protein aggregates in neurodegenerative diseases such as Alzheimer's and Parkinson's. Defects in ATG12 conjugation can lead to reduced autophagic flux and neuronal death. Modulating ATG12 conjugating enzyme activity may therefore offer a therapeutic avenue for enhancing clearance of aggregated proteins.
Infectious Diseases
Pathogens have evolved mechanisms to subvert host autophagy. The SARS-CoV-2 PLpro protein acts as a deconjugase that regulates N-degron recognin-mediated autophagy, potentially interfering with ATG12 conjugation and other ubiquitin-like pathways. Understanding how viral proteins modulate ATG12 conjugating enzyme activity could inform antiviral strategies.
Inflammatory Diseases
Autophagy plays a key role in immune regulation and inflammation. Polymorphisms in ATG16L1, a component of the ATG12-ATG5 conjugate complex, are associated with Crohn's disease, highlighting the importance of this pathway in inflammatory bowel disease. Defects in ATG12 conjugation may contribute to impaired bacterial clearance and chronic inflammation.
From Atg12 conjugating enzyme activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| What is the effect of ATG10 loss on autophagy? | ATG10 knockout cell lines (e.g., HeLa, HEK293T) |
| How does a point mutation in ATG10 catalytic cysteine affect conjugation? | ATG10 Cys-to-Ala point mutant knock-in cells |
| What is the localization of ATG12-ATG5 conjugate? | ATG12 or ATG5 tagged knock-in cells (e.g., GFP-ATG12) |
| Can overexpression of ATG10 enhance autophagy? | ATG10 overexpression stable cell lines |
| What is the role of ATG12-ATG3 interaction in cancer? | ATG12 or ATG3 knockout/overexpression in cancer cells |
| How does PLpro affect ATG12 conjugation? | PLpro overexpression in cells with ATG12 reporter |
How to Study the Atg12 conjugating enzyme activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Western blot | ATG12-ATG5 conjugate levels | Assessing conjugation activity in cells [1,3] |
| Immunoprecipitation | Protein-protein interactions | Detecting ATG12-ATG5 or ATG10-ATG12 complexes |
| Fluorescence microscopy | LC3 puncta formation | Monitoring autophagosome formation downstream of conjugation [3,5] |
| In vitro conjugation assay | Thioester transfer activity | Measuring enzymatic activity of ATG10 mutants [1,6] |
| X-ray crystallography | Three-dimensional structure | Understanding catalytic mechanism and interfaces |
| CRISPR knockout | Gene function | Determining requirement of ATG10 in autophagy |
| RNA-seq | Transcriptional changes | Identifying genes regulated by ATG12 conjugation |
| Proteomics | Protein interactions and modifications | Mapping the ATG12 interactome |
Western Blotting and Immunoprecipitation
Western blotting is commonly used to detect the formation of ATG12-ATG5 conjugate, which appears as a higher molecular weight band compared to free ATG12 [1,3]. Immunoprecipitation followed by western blotting can confirm the interaction between ATG12 and ATG5 or ATG10. These methods are essential for assessing the activity of ATG10 mutants and the effects of regulatory factors.
Fluorescence Microscopy
Fluorescence microscopy with GFP-LC3 or other ATG8 reporters is widely used to monitor autophagosome formation, which is downstream of ATG12 conjugation [3,5]. Co-localization of ATG12 or ATG5 with autophagosomal markers can reveal the spatial dynamics of the conjugation machinery. Live-cell imaging allows real-time tracking of autophagosome biogenesis.
In Vitro Conjugation Assays
Reconstituted in vitro assays using purified ATG7, ATG10, ATG12, and ATG5 can directly measure Atg12 conjugating enzyme activity [1,6]. These assays typically use radiolabeled or fluorescently tagged Atg12 to monitor thioester formation and transfer. They are invaluable for dissecting the enzymatic mechanism and testing inhibitors.
Structural Biology
X-ray crystallography and cryo-electron microscopy have been used to determine the structures of ATG12-ATG5 conjugate and its complexes with ATG3 [5,8]. These studies provide atomic-level insights into the catalytic mechanism and interaction interfaces [5,8]. Structural information can guide the design of small molecule modulators.
How CRISPR Can Be Used to Study GO:0061651 Atg12 conjugating enzyme activity
Knockout
CRISPR knockout of ATG10 or ATG12 is used to abolish Atg12 conjugating enzyme activity and study its consequences on autophagy. For example, ATG10 knockout in Arabidopsis thaliana results in defective autophagic vesicle formation. In mammalian cells, ATG10 knockout impairs ATG12-ATG5 conjugation and LC3 lipidation, leading to accumulation of autophagic substrates [1,4]. These models are essential for validating the role of the enzyme in specific cellular contexts.
Point Mutation
Point mutations in the catalytic cysteine of ATG10 (e.g., Cys-to-Ala) can be introduced using CRISPR to specifically inactivate the conjugating activity without affecting protein stability. Such models help distinguish between the enzymatic activity and other potential functions of ATG10. Similarly, mutations in the ATG12 C-terminus can block conjugation and reveal its importance in autophagy.
Knock-in
Knock-in of tagged versions of ATG12 or ATG5 (e.g., GFP or HA tags) allows for real-time tracking and biochemical isolation of the conjugate. CRISPR-mediated knock-in of disease-associated mutations, such as ATG16L1 T300A, can model human inflammatory diseases and study their impact on ATG12 conjugation. These models provide physiological expression levels and avoid artifacts from overexpression.
Overexpression
Overexpression of ATG10 or ATG12 using CRISPR activation or lentiviral vectors can enhance Atg12 conjugating enzyme activity and autophagy [1,4]. This approach is useful for studying the effects of increased conjugation on cellular processes and for identifying downstream targets. However, overexpression may lead to non-physiological effects, so careful controls are needed.
How EDITGENE Supports Atg12 conjugating enzyme activity Research
Researchers studying Atg12 conjugating enzyme activity-related genes often need to determine whether a candidate gene is causally involved in autophagy, disease progression, or therapeutic response. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant cell types. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate such studies, from single gene knockout to genome-wide library screening.
Contact EDITGENE today to design your custom CRISPR model for Atg12 conjugating enzyme activity research.
Frequently Asked Questions About Atg12 conjugating enzyme activity
What is Atg12 conjugating enzyme activity?
Atg12 conjugating enzyme activity (GO:0061651) is a molecular function that transfers Atg12 from one protein to another via thioester bonds, using a cysteine-based E2 mechanism. It is essential for autophagy.
What genes are involved in Atg12 conjugating enzyme activity?
The key genes are ATG10 (the E2 enzyme), ATG12 (the ubiquitin-like protein), ATG5 (the target), and ATG7 (the E1 enzyme) [1,3,6].
What is the role of ATG10 in autophagy?
ATG10 is the E2-like enzyme that conjugates ATG12 to ATG5, forming the ATG12-ATG5 conjugate that is required for LC3 lipidation and autophagosome formation [1,3].
How is Atg12 conjugating enzyme activity regulated?
It is regulated by upstream signals such as mTOR and AMPK, by RNA molecules, and by viral proteins like SARS-CoV-2 PLpro [2,6,7].
What diseases are associated with Atg12 conjugating enzyme activity?
Dysregulation is linked to cancer, neurodegenerative diseases, Crohn's disease, and viral infections [2,3,4].
What methods are used to study Atg12 conjugating enzyme activity?
Common methods include western blotting for ATG12-ATG5 conjugate, in vitro conjugation assays, fluorescence microscopy of LC3 puncta, and structural biology [1,3,5,8].
Can CRISPR be used to study Atg12 conjugating enzyme activity?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect the function of ATG10 and ATG12 in autophagy [1,4].
What is the ATG12-ATG5 conjugate?
It is the product of Atg12 conjugating enzyme activity, a covalent complex that acts as an E3-like enzyme to promote ATG8 lipidation [3,5].
Is Atg12 conjugating enzyme activity conserved across species?
Yes, the ATG12 conjugation system is conserved from yeast to plants and humans, with ATG10 as the E2 enzyme [1,6].
How can I model Atg12 conjugating enzyme activity defects in cells?
EDITGENE offers custom CRISPR knockout, point mutation, and knock-in cell lines for ATG10, ATG12, and related genes to model defects in this pathway [1,4].
Conclusion
The Atg12 conjugating enzyme activity (GO:0061651) is a fundamental molecular function in autophagy, catalyzing the transfer of Atg12 to ATG5 and initiating a cascade that leads to autophagosome formation. Its only known enzyme, ATG10, is conserved across eukaryotes and is essential for development and stress responses [1,6]. Dysregulation of this activity contributes to cancer, neurodegeneration, and infectious diseases, making it a target of intense research [2,4]. Advances in structural biology and CRISPR-based models have provided deep insights into the mechanism and regulation of this activity [5,8]. EDITGENE's comprehensive services, including knockout, point mutation, knock-in, overexpression, and library screening, empower researchers to further dissect the roles of ATG10 and ATG12 conjugation in health and disease.
References
- 1. Phillips AR et al.. 2008. The ATG12-conjugating enzyme ATG10 Is essential for autophagic vesicle formation in Arabidopsis thaliana.. Genetics 178(3):1339-53 PMID: 18245858
- 2. Ayala-Torres C et al.. 2025. Regulation of N-degron recognin-mediated autophagy by the SARS-CoV-2 PLpro ubiquitin deconjugase.. Autophagy 21(5):1019-1038 PMID: 39723606
- 3. Hanada T et al.. 2007. The Atg12-Atg5 conjugate has a novel E3-like activity for protein lipidation in autophagy.. J Biol Chem 282(52):37298-302 PMID: 17986448
- 4. Kamel EM et al.. 2025. Targeting the ATG12-ATG3 protein-protein interaction: From structural insights to therapeutic opportunities in autophagy modulation.. Pathol Res Pract 273:156156 PMID: 40763565
- 5. Sakoh-Nakatogawa M et al.. 2013. Atg12-Atg5 conjugate enhances E2 activity of Atg3 by rearranging its catalytic site.. Nat Struct Mol Biol 20(4):433-9 PMID: 23503366
- 6. Nakatogawa H. 2013. Two ubiquitin-like conjugation systems that mediate membrane formation during autophagy.. Essays Biochem 55:39-50 PMID: 24070470
- 7. Shao Y et al.. 2007. Stimulation of ATG12-ATG5 conjugation by ribonucleic acid.. Autophagy 3(1):10-6 PMID: 16963840
- 8. Otomo C et al.. 2013. Structure of the human ATG12~ATG5 conjugate required for LC3 lipidation in autophagy.. Nat Struct Mol Biol 20(1):59-66 PMID: 23202584
